These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 6208639)
1. Effect of long-term administration of paromomycin sulfate on the level of serum albumin and gamma-globulin in human cirrhosis. Tarao K; Iwamura K Tokai J Exp Clin Med; 1983 Nov; 8(4):349-57. PubMed ID: 6208639 [TBL] [Abstract][Full Text] [Related]
2. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial. Bode C; Schäfer C; Fukui H; Bode JC Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106 [TBL] [Abstract][Full Text] [Related]
3. Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man. Tarao K; Iwamura K Tokai J Exp Clin Med; 1983 Jan; 8(1):71-8. PubMed ID: 6612754 [TBL] [Abstract][Full Text] [Related]
4. Effect of paromomycin sulfate on endotoxemia in patients with cirrhosis. Tarao K; Moroi T; Hirabayashi Y; Ikeuchi T; Endo O; Takamura Y J Clin Gastroenterol; 1982 Jun; 4(3):263-7. PubMed ID: 7096960 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131 [TBL] [Abstract][Full Text] [Related]
6. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS; Wang BE; Wang TL; Jia JD; Qian LX Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205 [TBL] [Abstract][Full Text] [Related]
7. Control of endotoxinemia in liver disease by lactulose and paromomycin. Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Habu D; Nishiguchi S; Nakatani S; Lee C; Enomoto M; Tamori A; Takeda T; Ohfuji S; Fukushima W; Tanaka T; Kawamura E; Shiomi S Hepatogastroenterology; 2009; 56(96):1719-23. PubMed ID: 20214224 [TBL] [Abstract][Full Text] [Related]
9. Testosterone in the management of cirrhosis of the liver--a controlled study. Puliyel MM; Vyas GP; Mehta GS Aust N Z J Med; 1977 Dec; 7(6):17-30. PubMed ID: 350213 [TBL] [Abstract][Full Text] [Related]
10. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216 [TBL] [Abstract][Full Text] [Related]
11. [Effect of an anabolic steroid (methenolone enanthate) on the intra- and extravasal albumin pool in liver cirrhosis]. Knöbel H; Becker K Z Gastroenterol; 1975 Oct; 13(6):583-7. PubMed ID: 1224752 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752 [TBL] [Abstract][Full Text] [Related]
14. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Hewitt RG; Yiannoutsos CT; Higgs ES; Carey JT; Geiseler PJ; Soave R; Rosenberg R; Vazquez GJ; Wheat LJ; Fass RJ; Antoninievic Z; Walawander AL; Flanigan TP; Bender JF Clin Infect Dis; 2000 Oct; 31(4):1084-92. PubMed ID: 11049793 [TBL] [Abstract][Full Text] [Related]
15. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220 [TBL] [Abstract][Full Text] [Related]
16. [Study on the influence factors of the serum fibrosis markers]. Cai WM; Tao J; Weng HL; Liu RH Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736 [TBL] [Abstract][Full Text] [Related]
17. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Koruk M; Onuk MD; Akçay F; Savas MC Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754 [TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of recombinant growth hormone therapy for liver cirrhosis with hypoproteinemia]. Liu SJ; Tang WL; Shen SR Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):398-400. PubMed ID: 14653129 [TBL] [Abstract][Full Text] [Related]
19. [Chronic liver diseases with normal blood protein levels]. Buzzelli G; Gallerini L; Guarducci AM; Laffi G; Mazzanti R; Smorlesi C; Gentilini P Recenti Prog Med; 1977 Nov; 63(5):497-526. PubMed ID: 75556 [No Abstract] [Full Text] [Related]
20. [The value of serum markers in evaluating liver fibrotic changes]. Hu YY; Liu P; Liu C; Liu CH; Xu LM Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]